Please assess the completion status of the following clinical trial:

Trial Title: Improving Control and Reducing the Risk of Hypoglycemic Episodes in Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* 18 years of age or older~* Have type 1 diabetes as defined by the American Diabetes Association or by the judgment of the physician~* Willing to participate for up to one year~* Perform routine blood glucose checks 3-4 times a day~* Complete monthly diaries of the occurrence of severe and moderate hypoglycemic episodes~* Have 6 hemoglobin A1c (HgbA1c) drawn~* Have a mixed meal tolerance test to assess for residual pancreatic insulin secretion~Exclusion Criteria:~* Age \< 18 years~* Currently abusing alcohol or drugs~* Severe depression or psychosis~* Significant mental impairment~* Inability to use a glucometer and a hand held computer~* Pregnant or desire to achieve pregnancy within the following year (females)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group A Order: SMBG, IBMF-1, IBMF-2 (Type: EXPERIMENTAL): Group A performed routine self-monitored blood glucose (SMBG) alone (level 1), followed sequentially by Integrated Biobehavioral Monitoring \& Feedback - 1 (IBMF-1) level 2 and Integrated Biobehavioral Monitoring \& Feedback - 2 (IBMF-2) level 3. Each level continued for 3 months.
- Group B Order: IBMF-1, IBMF-2, SMBG (Type: EXPERIMENTAL): Group B began with Integrated Biobehavioral Monitoring \& Feedback - 1 (IBMF-1) level 2, followed by level 3, Integrated Biobehavioral Monitoring \& Feedback - 2 (IBMF-2) and then level 1 (SMBG only). Each level continued for 3 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).